Volume 7, Issue 9 WAO Events and Programs - September 2010
Note from the President
The 1st World Allergy Organization (WAO) International Scientific Conference, entitled "Asthma and Comorbid Conditions: Expanding the Practice of Allergy for Optimal Patient Care," is scheduled for approximately three months from now, December 5 - 8, 2010, in Dubai, United Arab Emirates (UAE).
The focus of the scientific program will be extraordinarily unique, one of a kind, from which physicians will learn about varied comorbid conditions associated with asthma. The faculty are an internationally recognized "Who's Who" in the world, each one of whom will participate in a variety of different educational venues including postgraduate lectures, symposia, plenary sessions, "hands-on" conferences and poster presentations. Comorbid conditions covered are too numerous to mention but some of them include sleep apnea, various forms of rhinitis, vocal cord dysfunction, obesity, osteoporosis and osteopenia, endocrine disorders, and psychological problems. There will be sessions on food challenge testing, the role of bone scanning to diagnose osteoporosis and osteopenia, managing chronic cough, spirometry, skin testing, rhinoscopy, management of sleep disorders, smoking cessation, aspirin desensitization, use of nitric oxide and other markers of inflammation, bronchial provocation testing, practical aspects of immunotherapy, and weight management.
Dubai is one of the seven emirates of the UAE located south of the Persian Gulf on the Arabian Peninsula. It dates from 1799, its geographical location making it an important trading hub by the beginning of the 20th century. Dubai has attracted world attention for its large construction projects and architectural highlights. It is known as the "shopping capital" of the Middle-East, and its rich collection of buildings and structures include the Burj Khalifa, currently the world's largest building.
As President of WAO, I will be honored to greet you at the opening ceremony, December 5, to which all are invited. Remember, this conference is intended to expand the practice of allergy for optimal patient care. Many of the subjects covered are those which will enhance the skills of the practitioner to take care of patients with asthma, other chronic respiratory problems, and their comorbid conditions. Please go to the WAO website at www.worldallergy.org and register for this most unusual and wonderful conference, in fact, a first of its kind.
See you there!
Richard F. Lockey, MD
Small Airways Working Group Lecture
WAO's Small Airways Diseases Working Group project will host a lecture on "Particle Deposition and Small Airways in Asthma", presented by Lanny J. Rosenwasser, Chair, WAO Small Airways Diseases Working Group; Chief Editor, WAO Journal & Secretary General, WAO.
The 60th Annual Meeting of Japanese Society of Allergology
WAO Journal Chief Editor Interviews
Lanny J. Rosenwasser, MD, Editor-in-Chief, recently spoke with Alessandro Fiocchi, MD, about the recent publication he co-authored, "World Allergy Organization (WAO) Diagnosis and Rational for Action against Cow's Milk Allergy (DRACMA) Guidelines" (Fiocchi A, Brozek J, Schünemann H, Bahna SL, von Berg A, Beyer K, Bozzola M et al., World Allergy Organization Journal 2010; 3(4): 57-61. Full text.
To listen to this interview, download it from the podcast section of the WAO Journal.
WAO Allergic Diseases Resource Center -
SUBMIT YOUR ABSTRACT AND REGISTER ONLINE TODAY
To Register for WISC 2010, click here.
To Submit a Late-Breaking Abstract or Review Abstract Submission Guidelines, click here.
To Book your Accommodations and View Optional Tour Information, click here.
Scientific Program Highlights
To view the WISC 2010 Invited Speakers, click here.
To view the WISC 2010 Preliminary Scientific Program, click here.
In This Edition
World Allergy Organization Journal
Lanny J. Rosenwasser, MD - Editor-in-Chief
Association of BDNF Gene Polymorphism with Asthma in Polish Children
Probiotics in Treatment of Allergic Rhinitis
New Perspectives in Hereditary Angioedema: Molecular Mechanisms and Therapeutic Choices
1. Introduction, New Perspectives in Hereditary Angioedema: Molecular Mechanisms and Therapeutic Choices
2. The Pathophysiology of Hereditary Angioedema
3. Hereditary Angioedema: Recombinant and Purified Human C1 Inhibitors
4. A Review of HAE Treatments: Kallikrein Inhibitors and Bradykinn Type 2 Receptor
5. Summary and Conclusions, New Perspectives in Hereditary Angioedema: Molecular Mechanisms and Therapeutic Choices
HOW TO ACCESS THE WAO JOURNAL
Go to the WAO website (www.worldallergy.org). Click "Members Only" and you will be provided with instructions on how to access the full text of all articles published in the WAO Journal. To enjoy continual access, return to www.WorldAllergy.org and Members Only each time to newly access the full text.
Not a member? Sign up for the WAO Journal at: www.waojournal.org
NEW CASE REPORT!
A Patient with Facial Rash and Angioedema
Editor: Bob Q. Lanier, MD
Upcoming WAO Activities in September
22-24 September, Barcelona, Spain
26 September, Gargnano, Italy
Upcoming Member Society Meetings
Georgia Association of Allergology and Clinical Immunology Annual Meeting
XXVII Congress of Czech and Slovak Allergists and Clinical Immunologists
Third International Congress of Allergy and Immunology
Israeli Association of Territorial and Hospital Allergists Annual Meeting
EAACI/GA2LEN Allergy School "Allergy and Immunotheraphy"
Annual Conference of Indian College of Allergy, Asthma and Applied Immunology (ICAAI) 2010
4th International Symposium on Molecular Allergology (ISMA) 2010
Information for the Practicing Allergist
The World Allergy Organization's mission is to be a global resource and advocate in the field of allergy, advancing excellence in clinical care through education, research and training as a world-wide alliance of allergy and clinical immunology societies. Visit us on the Web at www.worldallergy.org
World Allergy Organization (WAO)
You have received this message because you are a member of a WAO Member Society, you have subscribed for the monthly e-letter or had previous contact with the World Allergy Organization. If you prefer not to receive WAO News & Notes Messages, please reply to this email with REMOVE in the subject line. To be removed from all WAO messages, please reply with REMOVE ALL in the subject line.